Casdin Capital specializes in life sciences, biotechnology, and pharmaceutical investments. The firm focuses on companies leveraging molecular information and advanced technologies across healthcare, biotech, synthetic biology, and related sectors. Casdin Capital's investment approach is rooted in research, driven by data, and validated by returns.
The firm's portfolio includes notable companies such as 23andMe, Ginkgo Bioworks, and Flatiron Health. Casdin Capital's investments span various stages, with a particular emphasis on Series A to C rounds. The firm's expertise in the life sciences sector and data-driven approach provide valuable support to its portfolio companies, helping them navigate the complex and dynamic healthcare and biotechnology landscapes.
Casdin Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
